OrCam Technologies Due Diligence
Run due diligence on OrCam Technologies: check compliance and get alerts when suppliers change.
Israel · www.orcam.com · 9 vendors
OrCam Technologies develops and manufactures AI-powered assistive technology devices for individuals who are visually impaired, blind, or have reading challenges. Their products, such as OrCam MyEye and OrCam Read, use computer vision and machine learning to provide audio feedback, allowing users to read text, recognize faces, and identify products, fostering independence and improving quality of life.
Resilience scores
- Digital Sovereignty: 0
- Digital Resilience: 8
- Financial Resilience: 5
Technology vendors
- Amazon Web Services (aws) — Technology — United States
- Stripe, Inc. — Financial Services — United States
- The Linux Foundation — Technology — United States
- and 7 more
Services catalogue
2 services in catalogue across 2 categories; runs on 9 sub-vendors.
- AI vision devices
- Vulnerability scanning
Insights
Last updated 2026-08-15 · revision 1
9 direct vendors, 127 subvendors
Direct vendors by controlling owner country (sample)
- United States: 8
- Germany: 1
Subvendors by controlling owner country (sample)
- Japan: 2
- Unknown: 2
- Denmark: 1
Compliance
10 in-scope frameworks identified; showing 3.
SOC 2 (source) — No public evidence
Evidence: https://www.orcam.com/en-us/privacy-statement, https://www.orcam.com/en-us/home
GDPR (source) — Evidence found
Evidence: https://www.orcam.com/en-us/privacy-statement, https://www.orcam.com/en-us/terms-of-use, https://www.orcam.com/en-us/orcam-products-privacy-statement, https://www.orcam.com/en-us/cookies-policy
EU AI Act (source) — No public evidence
Evidence: https://www.orcam.com/en-us/home, https://www.orcam.com/en-us/orcam-myeye-3-pro, https://www.orcam.com/en-us/terms-of-use
Financials
Three-year financials
- 2024:
- 2023:
- 2022:
Financial Resilience Score: 5/10
OrCam Technologies is a private Israeli AI/assistive-tech unicorn co-founded by the Mobileye founders (Amnon Shashua and Ziv Aviram), which lends significant credibility, access to capital, and top-tier talent. The company has raised over US$130 million cumulatively, was valued at approximately US$1 billion in 2019, and has built a differentiated IP portfolio in on-device computer vision and OCR. Its global footprint across ~50 countries and ~25 languages, combined with a defensible niche in assistive medical devices (often reimbursed by insurers/veterans agencies), provides some revenue durability. However, the company faces material challenges. The shelved 2021 Tel Aviv IPO (targeted at US$2–3 billion valuation) and reported ~20% workforce layoffs in 2023 suggest ongoing profitability struggles and a difficult commercial environment. Press-leaked 2020 revenue of ~US$34 million alongside continuing net losses points to a company still burning cash. Competitive pressure from smartphones with built-in accessibility features, smart glasses (Meta/Ray-Ban), and emerging AI wearables (Envision, Humane) threatens OrCam's premium price points (US$2,000–4,500 per device). Additional risks include the lack of public financial transparency, dependence on reimbursement policy in key markets (Germany, US veterans schemes), a relatively narrow addressable market, and geopolitical/operational exposure due to Israel-based R&D and manufacturing during the 2023–2024 conflict period. Overall, resilience is moderate—supported by strong founders and IP, but constrained by unprofitability, competitive threats, and limited financial visibility.
Key strengths: Strong founder pedigree (Mobileye co-founders Shashua and Aviram), Cumulative funding of >US$130 million with Intel Capital among backers, US$1 billion unicorn valuation achieved in 2019, Differentiated proprietary computer-vision and OCR IP portfolio, Global distribution across ~50 countries and ~25 languages, Defensible niche in assistive devices with insurance/reimbursement support, Continued product refresh cadence (MyEye 3 Pro, Read 5 in 2024–2025)
Risk factors: No public financial transparency as a private company, Ongoing cash burn and unprofitability, Shelved 2021 IPO indicating market/valuation challenges, ~20% workforce layoffs reported in 2023, Competitive pressure from smartphones, smart glasses, and AI wearables, Narrow addressable market with high ASP dependence, Reimbursement/policy dependence in key markets, Geopolitical and operational risk from Israel-based operations
Revenue by geography
- Israel: 0%
- Asia-Pacific: 0%
- North America: 0%
- Western Europe: 0%
Revenue by product/service
- OrCam Read: 0%
- OrCam Learn: 0%
- OrCam MyEye: 0%
Workforce by country
- Europe: 0
- Israel: 0
- United States: 0
Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.